Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $45.48 million. The enterprise value is -$90.88 million.

Market Cap	45.48M
Enterprise Value	-90.88M

Important Dates

The next estimated earnings date is Tuesday, May 20, 2025, before market open.

Earnings Date	May 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 17.23 million shares outstanding. The number of shares has increased by 1.59% in one year.

Current Share Class	17.23M
Shares Outstanding	17.23M
Shares Change (YoY)	+1.59%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	29.13%
Float	11.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.32
P/TBV Ratio	0.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.84, with a Debt / Equity ratio of 0.06.

Current Ratio	5.84
Quick Ratio	5.53
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.57% and return on invested capital (ROIC) is -40.44%.

Return on Equity (ROE)	-63.57%
Return on Assets (ROA)	-36.68%
Return on Invested Capital (ROIC)	-40.44%
Return on Capital Employed (ROCE)	-96.55%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-30.16%
50-Day Moving Average	2.55
200-Day Moving Average	3.29
Relative Strength Index (RSI)	57.28
Average Volume (20 Days)	14,064,519

Short Selling Information

The latest short interest is 965,834, so 5.61% of the outstanding shares have been sold short.

Short Interest	965,834
Short Previous Month	562,784
Short % of Shares Out	5.61%
Short % of Float	8.17%
Short Ratio (days to cover)	0.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-138.26M
Pretax Income	n/a
Net Income	-128.51M
EBITDA	-134.75M
EBIT	-138.26M
Earnings Per Share (EPS)	-$7.58

Full Income Statement

Balance Sheet

The company has $144.39 million in cash and $8.02 million in debt, giving a net cash position of $136.36 million or $7.92 per share.

Cash & Cash Equivalents	144.39M
Total Debt	8.02M
Net Cash	136.36M
Net Cash Per Share	$7.92
Equity (Book Value)	140.50M
Book Value Per Share	8.22
Working Capital	126.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$128.55 million and capital expenditures -$92,000, giving a free cash flow of -$128.64 million.

Operating Cash Flow	-128.55M
Capital Expenditures	-92,000
Free Cash Flow	-128.64M
FCF Per Share	-$7.47

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.59%
Shareholder Yield	-1.59%
Earnings Yield	-282.56%
FCF Yield	-282.83%

Analyst Forecast

The average price target for Mural Oncology is $13.00, which is 392.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	392.42%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	6.08%
EPS Growth Forecast (5Y)	-24.69%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a